These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. PAR2 Modulators Derived from GB88. Yau MK; Liu L; Suen JY; Lim J; Lohman RJ; Jiang Y; Cotterell AJ; Barry GD; Mak JY; Vesey DA; Reid RC; Fairlie DP ACS Med Chem Lett; 2016 Dec; 7(12):1179-1184. PubMed ID: 27994760 [TBL] [Abstract][Full Text] [Related]
12. Sensitization of ASIC3 by proteinase-activated receptor 2 signaling contributes to acidosis-induced nociception. Wu J; Liu TT; Zhou YM; Qiu CY; Ren P; Jiao M; Hu WP J Neuroinflammation; 2017 Jul; 14(1):150. PubMed ID: 28754162 [TBL] [Abstract][Full Text] [Related]
13. Dual effect of the novel peptide antagonist K-14585 on proteinase-activated receptor-2-mediated signalling. Goh FG; Ng PY; Nilsson M; Kanke T; Plevin R Br J Pharmacol; 2009 Dec; 158(7):1695-704. PubMed ID: 19917067 [TBL] [Abstract][Full Text] [Related]
14. Pharmacophore-based virtual screening, biological evaluation and binding mode analysis of a novel protease-activated receptor 2 antagonist. Cho NC; Seo SH; Kim D; Shin JS; Ju J; Seong J; Seo SH; Lee I; Lee KT; Kim YK; No KT; Pae AN J Comput Aided Mol Des; 2016 Aug; 30(8):625-37. PubMed ID: 27600555 [TBL] [Abstract][Full Text] [Related]
15. Development and evaluation of small peptidomimetic ligands to protease-activated receptor-2 (PAR2) through the use of lipid tethering. Boitano S; Hoffman J; Tillu DV; Asiedu MN; Zhang Z; Sherwood CL; Wang Y; Dong X; Price TJ; Vagner J PLoS One; 2014; 9(6):e99140. PubMed ID: 24927179 [TBL] [Abstract][Full Text] [Related]